Conditions

In this Exclusive Interview transcript, George Bray talks with Diabetes in Control Medical Editor Joy Pape during the AACE 2018 convention in Boston about viewing obesity as a chronic disease process and the future of treatment.

In this Exclusive Interview, George Bray talks with Diabetes in Control Medical Editor Joy Pape during the AACE 2018 convention in Boston about the disease process of obesity.

In part 1 of this Exclusive Interview, George Bray talks with Diabetes in Control Medical Editor Joy Pape about the primary messages from the World Obesity Federation position statements.

In part 2 of this Exclusive Interview, George Bray talks with Diabetes in Control Medical Editor Joy Pape about the inequality of obesity and the issues with moving forward in solving the obesity problem.

In part 3, the conclusion of this Exclusive Interview, George Bray talks with Diabetes in Control Medical Editor Joy Pape about the possible methods and strategies for curtailing the obesity epidemic.

Sitagliptin showed greater glycemic efficacy over dapagliflozin when added onto existing therapy.

The SUSTAIN trials showed significant reductions in weight, but the true reason for the weight loss still unknown.

SGLT shown as useful adjunctive agent when insulin monotherapy fails, but decrease in insulin use may prove harmful.

Scientists find dramatic weight loss may reverse type 2 diabetes in some patients.

Elevated eGR fund to possibly lead to renal damage.